Where can researchers source third-party tested Selank?

Midwest Peptide supplies research-grade Selank with a Certificate of Analysis included for every batch, validated by HPLC purity and mass spectrometry identity testing.

Age Verification

You must be 21 years or older to access this website. All products are for research use only.

Are you 21 years of age or older?

By entering, you confirm that you are at least 21 years old and agree to our terms of service.

Memorial Day: 15% off code MEMDAY15Memorial Day Sale — 15% off site-wide with code MEMDAY15

Free shipping on every orderFree shipping on every order

5% off with Zelle or Apple CashSave an extra 5% when you pay with Zelle or Apple Cash

Bulk pricing discounts up to 18%Bulk pricing discounts up to 18% off

Selank GABA Research: Anxiolytic Studies | Midwest Peptide

Selank BDNF Research: Published Neurobiology StudiesPrev|Selank Tuftsin Research: Russian Peptide Research HistoryNext

Selank GABA Research: Anxiolytic Studies in Animal Models

Q: Is Selank approved for human use?

No. Selank is not approved by the FDA for any human therapeutic use. It is supplied strictly for in-vitro and preclinical research purposes by qualified investigators.

Selank · Published April 9, 2026 · Updated May 18, 2026 · 7 min read

Quick Answer

Selank GABA research examines GABA receptor expression, inhibitory currents, and anxiolytic behavioral endpoints in rodent models. Studies measure GABA-A receptor binding, behavioral tests like elevated plus maze, and anxiety-related biomarkers across standardized anxiolytic research protocols. For research use only, not for human consumption.

Selank GABA Research: Anxiolytic Studies in Animal Models

Research Use Only. All products are strictly for research use only (RUO). Not for human consumption. Products on this site are not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. By purchasing, you agree that you are a qualified researcher and that products will be used solely for in-vitro research purposes.

GABAergic Neurotransmission as a Research Target
Selank Effects on GABA Receptor Expression
Selank and GABAergic Inhibitory Currents
Anxiolytic Behavioral Endpoints in Selank Research
Comparison with Other Anxiolytic Research Tools
Open Research Questions
Conclusion
Related Research Articles
Explore Related Products
Frequently Asked Questions
Glossary

Selank GABA research has produced one of the most active areas of preclinical literature on synthetic neuropeptide modulation of GABAergic neurotransmission. GABA (gamma-aminobutyric acid) is the major inhibitory neurotransmitter in the mammalian central nervous system, and modulation of GABAergic signaling is one of the central topics in research on anxiolytic mechanisms. As the GABA pathway research component of the Selank research cluster, this article reviews the published literature on Selank effects on GABAergic systems and on anxiety-related endpoints in animal research models.

Frequently Asked Questions

What is Selank in research contexts?

Selank is a synthetic heptapeptide derived from the natural immunomodulatory tetrapeptide tuftsin and developed in Russian neuropeptide research. It is studied in preclinical models for anxiolytic effects, GABAergic modulation, BDNF expression, and immunomodulatory activity.

How does Selank produce anxiolytic effects via GABA?

Selank modulates GABA receptor expression and inhibitory currents in stress-relevant brain regions, increasing GABA-mediated inhibition without the sedation and motor impairment characteristic of benzodiazepines, producing a distinct anxiolytic profile in behavioral research.

What anxiolytic paradigms are used with Selank?

Standard rodent anxiety paradigms include elevated plus maze, light-dark box, open field test, and social interaction test. Endpoints quantify anxiety-related behaviors while complementary measures assess sedation, motor function, and cognitive impact distinct from benzodiazepine-like effects.

Is Selank approved for human use?

Glossary

Key terms used in this article.

Tuftsin: An endogenous tetrapeptide (Thr-Lys-Pro-Arg) liberated from the Fc domain of immunoglobulin G, the structural basis for Selank.
GABAergic: Pertaining to neurons, synapses, or signaling pathways using gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter.
Anxiolytic: Pertaining to compounds that reduce anxiety in behavioral or physiological studies.
BDNF: Brain-derived neurotrophic factor, a key neurotrophin supporting neuronal survival, synaptic plasticity, and learning.
Heptapeptide: A peptide consisting of seven amino acid residues; both Selank and Semax are heptapeptides.
GABA: Gamma-aminobutyric acid, the primary inhibitory neurotransmitter in the central nervous system.
Elevated Plus Maze: A classic rodent anxiety assay measuring time spent in open versus closed arms of a plus-shaped elevated maze.

More from the Blog

Continue exploring research insights and updates.

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Subcutaneous vs intranasal administration for CNS-targeted research peptides: how to choose between routes for DSIP, Selank, and Kisspeptin based on molecular size, brain access, pharmacokinetics, and the published literature.

May 5, 2026

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

FDA restricted compounded tirzepatide for human use when the shortage ended. The Research Use Only research peptide channel for tirzepatide (GLP-2 TZ) operates under entirely separate regulations.

May 5, 2026

For Research Use Only. Selank is intended exclusively for in vitro and preclinical research. It is not approved for human use, is not a drug, and should never be administered to humans or to animals outside of an authorized research protocol.

GABAergic Neurotransmission as a Research Target

GABA is the major inhibitory neurotransmitter in the mammalian central nervous system, providing the counterbalance to excitatory glutamate signaling that maintains normal neural function. GABAergic signaling is mediated primarily by GABA-A receptors (ionotropic receptors that allow chloride ion flow) and GABA-B receptors (metabotropic G protein coupled receptors). Together, these receptors regulate neuronal excitability throughout the brain and spinal cord.

The modulation of GABAergic signaling is one of the most studied topics in research on anxiety, sedation, and related endpoints in animal models. Compounds that enhance GABAergic signaling typically produce anxiolytic and sedative effects in research models, while compounds that reduce GABAergic signaling produce the opposite profile. The well established connection between GABAergic neurotransmission and anxiety-related endpoints has made the GABA system one of the most important targets in research on anxiolytic mechanisms.

In animal research models, GABAergic function is typically characterized through measurements of GABA receptor expression, GABAergic inhibitory currents in cultured neurons or brain slices, behavioral endpoints sensitive to GABAergic modulation (such as elevated plus maze, light-dark box, and similar tests), and various other approaches that probe the GABA system at different levels of analysis.

Selank Effects on GABA Receptor Expression

The published research on Selank and GABA includes effects on GABA receptor subunit expression in research animal models. Studies have characterized changes in the expression of various GABA-A receptor subunits in different brain regions following Selank administration in research animals, with the published findings supporting modulation of GABA receptor expression as one component of the Selank profile.

The specific subunits affected and the magnitude of the changes depend on the brain region examined, the duration of administration, and the experimental conditions. The general pattern in the published literature supports increased expression of certain GABA-A receptor subunits in regions involved in anxiety processing, consistent with the anxiolytic profile observed in behavioral studies of Selank.

The mechanism by which Selank affects GABA receptor expression is not fully understood and may involve direct effects on transcription factors that regulate receptor gene expression, indirect effects through other neurotransmitter systems, or longer term plasticity effects in the GABAergic system. These different possible mechanisms are still being characterized in the published literature.

Selank and GABAergic Inhibitory Currents

Beyond changes in receptor expression, Selank has been studied for its effects on GABAergic inhibitory currents in research models. Patch clamp electrophysiology in cultured neurons and in brain slice preparations has been used to characterize how Selank affects the magnitude and kinetics of GABA-mediated inhibitory postsynaptic currents.

The published findings generally support enhanced GABAergic inhibition in research models with Selank treatment, consistent with the receptor expression changes and with the behavioral anxiolytic profile. The mechanism may involve direct positive allosteric modulation of GABA receptors, increased availability of receptors at the postsynaptic membrane, or other mechanisms that enhance GABAergic neurotransmission.

These electrophysiological findings provide cellular-level evidence for Selank effects on GABA signaling that complements the receptor expression and behavioral findings. Together, the multi-level evidence supports a coherent picture of Selank as a positive modulator of GABAergic neurotransmission in research models.

Anxiolytic Behavioral Endpoints in Selank Research

The behavioral endpoints used in Selank anxiety research include several standardized tests that probe different aspects of anxiety-like behavior in rodent research models.

The elevated plus maze is one of the most widely used tests for anxiety-like behavior in rodents. The test measures how much time research animals spend in the open versus closed arms of an elevated plus-shaped maze. Animals with reduced anxiety-like behavior spend more time in the open arms, which are perceived as more threatening due to height and exposure. Selank administration in research animals has been associated with increased open arm time in this test, consistent with anxiolytic effects.

The light-dark box test is another standard anxiety test that measures the willingness of research animals to enter a brightly lit chamber connected to a dark chamber. Animals with reduced anxiety-like behavior spend more time in the light chamber. Selank research has reported increased light chamber time in this test, providing convergent evidence on the anxiolytic profile.

The open field test measures locomotor activity and exploratory behavior in an open arena, with anxiety-like behavior typically manifested as reduced exploration of the central area. Selank has been studied in this test for effects on both general locomotor activity and on the specific anxiety-like component of the behavior.

These behavioral endpoints provide convergent evidence on the anxiolytic profile of Selank in research models, consistent with the cellular and molecular findings on GABAergic modulation.

Comparison with Other Anxiolytic Research Tools

The benzodiazepine class of compounds is the most extensively studied class of GABA-A positive modulators in research, providing a reference point for understanding Selank effects on the GABA system. Benzodiazepines act as positive allosteric modulators of GABA-A receptors, enhancing GABA-mediated inhibitory currents through a well characterized binding site on the receptor. The anxiolytic effects of benzodiazepines in research models are mediated by this enhancement of GABAergic inhibition.

Selank produces some similar anxiolytic effects in research models, but the mechanism appears to be distinct from the benzodiazepine binding site. Research on the molecular mechanism of Selank in the GABA system is ongoing, and the published findings suggest that Selank may modulate GABAergic signaling through indirect or longer-term effects rather than through direct allosteric modulation at the benzodiazepine site.

This mechanistic distinction is important for research applications because it suggests that Selank may have a different profile of effects than benzodiazepines in research models, potentially with different selectivity for specific brain regions or different time courses of action. The comparative literature on Selank and benzodiazepines is one of the more conceptually interesting areas of synthetic peptide research.

For more on the broader Selank profile beyond GABAergic effects, see our companion article on Selank BDNF research and neurobiology studies.

Open Research Questions

Several open research questions remain in the Selank GABA literature. These include the precise molecular mechanism by which Selank affects GABAergic signaling, how the GABA effects of Selank vary across different brain regions involved in anxiety processing, and how Selank compares quantitatively with benzodiazepines and other anxiolytic research tools in standardized animal models. Each of these is a legitimate research opportunity for investigators studying neuropeptide modulation of GABAergic neurotransmission.

Conclusion

Selank GABA research provides a substantial body of preclinical evidence on synthetic neuropeptide modulation of GABAergic neurotransmission. The convergent findings on receptor expression changes, GABAergic inhibitory current effects, and anxiolytic behavioral endpoints support the use of Selank as a research tool for studies of anxiety mechanisms in animal models. For investigators using Selank 10mg as a research tool, the GABA literature provides essential context for experimental design.

For more on the full Selank research cluster, see the pillar overview article and the supporting articles on each major topic.

Selank is supplied by Midwest Peptide for research use only and is not intended for human administration.

Explore more peer-reviewed research and laboratory guides from our science team:

All products are third-party tested with a Certificate of Analysis (COA) included. For research use only.

VIP 10mg, 99%+ purity, COA included
Selank 10mg, 99%+ purity, COA included
Semax 10mg, 99%+ purity, COA included

Browse All Research Peptides →

Age Verification

Selank GABA Research: Anxiolytic Studies in Animal Models

Frequently Asked Questions

What is Selank in research contexts?

How does Selank produce anxiolytic effects via GABA?

What anxiolytic paradigms are used with Selank?

Is Selank approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

GABAergic Neurotransmission as a Research Target

Selank Effects on GABA Receptor Expression

Selank and GABAergic Inhibitory Currents

Anxiolytic Behavioral Endpoints in Selank Research

Comparison with Other Anxiolytic Research Tools

Open Research Questions

Conclusion

Ready to Start Your Research?

Where can researchers source third-party tested Selank?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?

Age Verification

Selank GABA Research: Anxiolytic Studies in Animal Models

Frequently Asked Questions

What is Selank in research contexts?

How does Selank produce anxiolytic effects via GABA?

What anxiolytic paradigms are used with Selank?

Is Selank approved for human use?

Glossary

More from the Blog

Subcutaneous vs Intranasal: Choosing an Administration Route for DSIP, Selank, and Kisspeptin in Research

Can I Still Buy Compounded Tirzepatide? (2026 Research Context)

GABAergic Neurotransmission as a Research Target

Selank Effects on GABA Receptor Expression

Selank and GABAergic Inhibitory Currents

Anxiolytic Behavioral Endpoints in Selank Research

Comparison with Other Anxiolytic Research Tools

Open Research Questions

Conclusion

Related Research Articles

Explore Related Products

Ready to Start Your Research?

Where can researchers source third-party tested Selank?

What's the Cheapest Way to Get Tirzepatide (GLP-2 TZ) for Research?